COMMUNIQUÉS West-GlobeNewswire

Pluristem’s PLX-R18 Improves Hematopoietic Transplantation as Reported in Scientific Journal Frontiers in Medicine
27/02/2018
HAIFA, Israel, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI ) (TASE: PSTI ), a leading developer of placenta-based cell therapy products, announced today that Frontiers in Medicine has [...]
GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency (EMA) for Cannabidiol for the Treatment of Tuberous Sclerosis
27/02/2018
LONDON and CARLSBAD, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and [...]
Transactions in relation to share buyback program
27/02/2018
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Epizyme Announces Date of Fourth Quarter and Full Year 2017 Results Conference Call and Upcoming Presentation at the Cowen 38th Annual Health Care Conference
27/02/2018
CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will host a conference [...]
Avivagen Announces CEO Update and January 31, 2018 Financial First Quarter Results
27/02/2018
OTTAWA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“ Avivagen ” or the “ Company ”), a life sciences innovation company with a series of patent protected products that support and [...]
PotNetwork Holding Inc. Exceeds 1 Million in Sales for First 15 Days of February
27/02/2018
FT LAUDERDALE, Fla., Feb. 27, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- PotNetwork Holding, Inc. (OTC Pink:POTN ) (“Company”) announced today that its wholly owned subsidiary, Diamond CBD, Inc., has reported that the [...]
Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results
27/02/2018
PLAINSBORO, N.J., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ) today reported financial results for the fourth quarter and full-year ended December 31, 2017. Highlights: [...]
Green Cures & Botanical Distribution, Inc. Partners with Humboldt Cannabis AF to Produce Licensed Cannabis and CBD Products
27/02/2018
LOS ANGELES, CA , Feb. 27, 2018 (GLOBE NEWSWIRE) -- Green Cures and Botanical Distribution, Inc. (OTC PINK: GRCU), an innovative hemp-infused nutrition, botanical, sports, and body care products company, has signed a [...]
Amarin Reports Record Fourth Quarter and Full Year 2017 Financial Results and Provides Update on Operations
27/02/2018
Record Revenue of $181.1 Million and $ 53.9 Million for Full Year and Fourth Quarter 2017 REDUCE-IT Cardiovascular Outcomes Study Remains on Schedule to Report Top-Line Results Before the End of Q3 2018 Management to [...]
Verona Pharma plc ("Verona Pharma" or the "Company") Reports Operational Update and Financial Results for Full Year Ended December 31, 2017
27/02/2018
LONDON, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (Verona Pharma), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
OSE Immunotherapeutics Granted Approval to Resume Patient Accrual in U. S. for Phase 3 Tedopi® Clinical Trial in Advanced Non-Small Cell Lung Cancer Patients Following Immune Checkpoint Inhibitor Treatment
27/02/2018
NANTES, France, Feb. 27, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announces that the first approvals to resume patient accrual in the global Tedopi ® Phase 3 trial have been [...]
Photocure ASA: Results for the fourth quarter of 2017
27/02/2018
Oslo, Norway, 27 February 2018: Photocure ASA (OSE: PHO ), today reported a revenue growth of 27% for the important U.S. market in the fourth quarter of 2017, contributing to Hexvix ® /Cysview ® revenues of NOK 39.4 [...]
Basilea reports significantly improved financial results in 2017
27/02/2018
54% increase in total revenue, amounting to CHF 101.5 million Operating loss reduced by 68% to CHF 14.1 million Cash position as of year-end 2017 increased to CHF 310.7 million License and distribution agreements in [...]
Vistin Pharma ASA : Fourth quarter 2017 results
27/02/2018
Oslo, Norway, 27 February 2018 Vistin Pharma had a revenue of NOK 41.6 million in the fourth quarter 2017, compared to NOK 32.5 million in the fourth quarter 2016. Adjusted EBITDA from continuing operations came to [...]
Targovax to present at Biologics World Nordic 2018
27/02/2018
Oslo, Norway, 27 February 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that the Company will present at the following [...]
Biocartis Group NV: Disclosure of a transparency notification
27/02/2018
PRESS RELEASE : REGULATED INFORMATION 27 February 2018, 07:00 CET Disclosure of a transparency notification (Article 14, paragraph 1 of the Belgian Act of 2 May 2007 on disclosure of major shareholdings) Mechelen, [...]
Arcturus Therapeutics Issues Statement Regarding Extraordinary General Meeting of Shareholders
27/02/2018
SAN DIEGO, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today announced that, based on the preliminary vote count provided by its transfer agent [...]
BioStem Technologies Inc. Announces Intent to Acquire GIINT
27/02/2018
Pompano Beach, FL, Feb. 26, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration in [...]
Kane Biotech Sues Nestlé
27/02/2018
WINNIPEG, Manitoba, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) today announced that it has filed a lawsuit against Nestec, Ltd., a/k/a Nestec, [...]

Pages